Drug Plan Fails, Signaling Thorny Path for Democrats’ $3.5 Trillion Bill
By BY EMILY COCHRANE AND MARGOT SANGER-KATZ
U.S.
https://ift.tt/3CiaH7y
Senior Democrats said they could still preserve elements of their plan to lower prescription drug prices, but they have little room for defections, and divisions remain on that and other issues.
New York Times
United States Politics and Government, Law and Legislation, Drugs (Pharmaceuticals), Prices (Fares, Fees and Rates)
September 16, 2021 at 12:10AM